Please use this identifier to cite or link to this item:
|Title:||Therapeutic Keratoplasty for Advanced Suppurative Keratitis||Authors:||Ti, S.-E.
|Issue Date:||May-2007||Citation:||Ti, S.-E., Scott, J.A., Janardhanan, P., Tan, D.T.H. (2007-05). Therapeutic Keratoplasty for Advanced Suppurative Keratitis. American Journal of Ophthalmology 143 (5) : 755-762.e2. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajo.2007.01.015||Abstract:||Purpose: To determine indications, therapeutic success, and corneal transplantation techniques for advanced medically uncontrolled infectious keratitis. Design: Retrospective, interventional case series. Methods: A review of 92 consecutive patients (1991 to 2002) who underwent therapeutic keratoplasty for acute infectious keratitis performed at Singapore National Eye Centre. Causative organism(s) were identified and outcomes were evaluated in terms of infectious cure (therapeutic success), graft clarity, and visual acuity. Results: Pseudomonas aeruginosa (58.7%) and Fusarium species (32.3%) were the predominant organisms for bacterial and fungal keratitis, respectively. Keratoplasty types included penetrating keratoplasty (PK; n = 80) and lamellar keratoplasty (n = 12). Mean graft diameter was 9.5 mm (range, 5.5 to 14 mm). Seventy-four patients (80.4%) achieved therapeutic success after one keratoplasty procedure, three patients were cured after a second keratoplasty. Life-table survival analysis computed the one-year therapeutic survival for bacterial and fungal keratitis as 76.6% and 72.4%, respectively (P = .76). The Kaplan-Meier one-year survival rate for PK optical clarity was 72%. Twenty-two patients underwent repeat keratoplasty for various reasons (optical, n = 8; recurrent primary infection, n = 7; perforation or subsequent new infections, n = 7). Of the 15 patients for whom therapy failed, 11 had fungal keratitis. Infection recurrence time was four days to one year. Most recurrences (n = 11) appeared within six weeks after surgery. Conclusions: Therapeutic keratoplasty may treat severe, refractory infectious keratitis effectively. High cure rates are achievable, although infection recurrence despite prolonged treatment remains a significant problem in fungal keratitis. © 2007 Elsevier Inc. All rights reserved.||Source Title:||American Journal of Ophthalmology||URI:||http://scholarbank.nus.edu.sg/handle/10635/92594||ISSN:||00029394||DOI:||10.1016/j.ajo.2007.01.015|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 15, 2021
WEB OF SCIENCETM
checked on Jan 15, 2021
checked on Jan 9, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.